INS and hypertriglyceridemia: This novel disease model exhibits fasting hyperglycaemia and hyperinsulinaemia, enhanced insulin secretion, tissue specific insulin resistance hypertriglyceridemia and structural changes in the endocrine pancreas and the kidney.